TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30230409

Group type: EXPERIMENTAL
Intervention: Agilepristone (AGL) 10 mg/kg SC q24h for two consecutive days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Agilepristone (AGL) + Misoprostol (MIS) 200 µg/cat PO q12h until abortion
Number of subjects: 28

Group type: COMPARATOR
Intervention: Misoprostol (MIS) 200 µg/cat PO q12h until abortion
Number of subjects: 28

Group type: COMPARATOR
Intervention: Misoprostol (MIS) 400 µg/cat PO q12h until abortion
Number of subjects: 28
Study: 28493641

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 802

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: New-onset AF
Number of subjects: 802

Group type: COMPARATOR
Intervention: Bivalirudin and UFH (combined analysis)
Number of subjects: 802
Study: 25957784

Group type: EXPERIMENTAL
Intervention: TACE plus Sorafenib (n = 24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: TACE plus placebo (n = 26)
Number of subjects: 50
Study: 24359514

Group type: EXPERIMENTAL
Intervention: Living in neighbourhoods with moderate slope levels
Number of subjects: 11406

Group type: EXPERIMENTAL
Intervention: Living in neighbourhoods with higher slope levels
Number of subjects: 11406

Group type: EXPERIMENTAL
Intervention: Increase of one percent in mean slope
Number of subjects: 11406
Study: 21550205

Group type: EXPERIMENTAL
Intervention: RBCs stored for 7 days or less (fresh arm)
Number of subjects: 2510

Group type: COMPARATOR
Intervention: Standard-issue RBCs stored, on average, 15 to 20 days (control arm)
Number of subjects: 2510
Study: 19327412

Group type: EXPERIMENTAL
Intervention: Preoperative coronary revascularization
Number of subjects: 101

Group type: COMPARATOR
Intervention: No preoperative coronary revascularization
Number of subjects: 101

Group type: COMPARATOR
Intervention: Medical treatment (no revascularization)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Coronary revascularization
Number of subjects: 101
Study: 22352857

Group type: EXPERIMENTAL
Intervention: Multidimensional Treatment Foster Care (MTFC)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Traditional community-based group care
Number of subjects: 166
Study: 16048810

Group type: EXPERIMENTAL
Intervention: External Qi-therapy (QT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo control therapy
Number of subjects: 40
Study: 12528607

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (200 micrograms daily)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Vehicle placebo
Number of subjects: 150
Study: 9483167

Group type: EXPERIMENTAL
Intervention: Cabergoline (0.25 to 4 mg once daily)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Levodopa (100 to 600 mg/day)
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 412

Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 412
Study: 8568162

Group type: EXPERIMENTAL
Intervention: LCM 1010 (ready to use eye drops)
Number of subjects: 97

Group type: COMPARATOR
Intervention: CBS 341A (eye drops to be reconstituted)
Number of subjects: 97
Study: 2229496

Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine (EMLA) cream (n = 58)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo cream (n = 25)
Number of subjects: 83
Study: 629190

Group type: EXPERIMENTAL
Intervention: Operant approach
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Modified sensory integrative approach
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combination of both methods
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 27
Study: 11413274

Group type: EXPERIMENTAL
Intervention: Gabapentin (1200 mg daily)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Vigabatrin (2000 mg daily)
Number of subjects: 8
Study: 30635439

Group type: EXPERIMENTAL
Intervention: Increased schooling duration due to policy reform
Number of subjects: 18929
Study: 29572094

Group type: EXPERIMENTAL
Intervention: ARC-AAT (4.0 mg/kg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 26998949

Group type: EXPERIMENTAL
Intervention: Individual Nutrition Therapy and Exercise Regime (alternate weekly visits from a physical therapist and dietitian)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Social visits for 6 months (control group)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Individual Nutrition Therapy and Exercise Regime
Number of subjects: 175
Study: 25059701

Group type: EXPERIMENTAL
Intervention: CT table strap placed around the torso only (intervention group)
Number of subjects: 51

Group type: COMPARATOR
Intervention: CT table strap placed around the torso and arms (control group)
Number of subjects: 51
Study: 22251436

Group type: EXPERIMENTAL
Intervention: Maraviroc 300 mg BID for 12 weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 110
Study: 20138472

Group type: EXPERIMENTAL
Intervention: Atrial electromechanical conduction time (EMT) measured by echocardiography
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group with sinus rhythm (SR)
Number of subjects: 53
Study: 17082513

Group type: EXPERIMENTAL
Intervention: cisplatin/paclitaxel
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: carboplatin/paclitaxel
Number of subjects: 103
Study: 15727644

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (one pass)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Q-switched Nd:YAG laser (three treatment sessions)
Number of subjects: 22
Study: 11885833

Group type: EXPERIMENTAL
Intervention: Doctor-held card
Number of subjects: 1275

Group type: EXPERIMENTAL
Intervention: Patient-held card
Number of subjects: 1275

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1275
Study: 9790083

Group type: EXPERIMENTAL
Intervention: Extracorporeal liver assist device (ELAD) hemoperfusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (intensive care alone)
Number of subjects: 12
Study: 9097772

Group type: EXPERIMENTAL
Intervention: Spiral computed tomography (CT)
Number of subjects: 34
Study: 2692763

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 20

Group type: COMPARATOR
Intervention: Trazodone
Number of subjects: 20
Study: 141860

Group type: EXPERIMENTAL
Intervention: 2‐Br‐ergocriptine (bromocriptine, CB‐154)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 12
Study: 29347825

Group type: EXPERIMENTAL
Intervention: FatherWorks intervention (15 session parenting intervention, 13 session employment class, paid internship, case management, and access to behavioral health services)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Care-as-usual (24/7 Dads)
Number of subjects: 328
Study: 30378221

Group type: EXPERIMENTAL
Intervention: CPAP with 15 cmH2 O
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CPAP with 4 cmH2 O
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CPAP with 0 cmH2 O
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All levels of CPAP (0, 4, and 15 cmH2 O)
Number of subjects: 10
Study: 28556766

Group type: EXPERIMENTAL
Intervention: B-Active2 (Enjoy Being Physically Active by Walking Safely: A Leisure Education Program)
Number of subjects: 44
Study: 25494719

Group type: EXPERIMENTAL
Intervention: STOMA psychosocial intervention
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 84
Study: 23597853

Group type: EXPERIMENTAL
Intervention: Interictal epileptiform discharges (IEDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Periodic epileptic discharges/subtle status epilepticus (PEDs/subtle SE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rhythmic fast activities background (RFAB) pattern
Number of subjects: 0
Study: 22011889

Group type: EXPERIMENTAL
Intervention: C&B Cement (CB)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ketac Cem (KC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: GC FujiCEM (FC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Water storage (T7 and T90)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no water storage)
Number of subjects: 20
Study: 19105432

Group type: EXPERIMENTAL
Intervention: Yishen Zhuanggu decoction (YSZGD), orally, one potion two times each day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Calcitonin (50 units, intramuscular, 2 times each week), Caltrate D (1 tablet, orally, once daily), Alfacalcidol Soft Capsules (0.5 units, orally, once daily)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no medicine)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: TCM group (YSZGD)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Western medicine group
Number of subjects: 90
Study: 16497637

Group type: EXPERIMENTAL
Intervention: Individualized nutrition and lifestyle counselling (at least twice a year)
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 1062
Study: 12910512

Group type: EXPERIMENTAL
Intervention: Mastectomy (MT)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Breast conservation therapy (BCT)
Number of subjects: 237
Study: 10321561

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with a standardized Dermatophagoides pteronyssinus (DP)‐D. farinae (DF) 50/50 extract, cumulative dose of about 104000 IR over 24 months.
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85

Group type: COMPARATOR
Intervention: Both groups (SLIT and placebo)
Number of subjects: 85
Study: 8561338

Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 1658863

Group type: EXPERIMENTAL
Intervention: Glycerol treatment
Number of subjects: 187

Group type: COMPARATOR
Intervention: No anti-edema treatment
Number of subjects: 187
Study: 6764750

Group type: EXPERIMENTAL
Intervention: bromocriptine
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: observation cycle
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 12 month follow-up
Number of subjects: 50
Study: 30928882

Group type: EXPERIMENTAL
Intervention: Positive political rhetoric
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Negative political rhetoric
Number of subjects: 280

Group type: COMPARATOR
Intervention: Neutral rhetoric
Number of subjects: 280
Study: 28481007

Group type: EXPERIMENTAL
Intervention: Celecoxib plus rabeprazole
Number of subjects: 55

Group type: COMPARATOR
Intervention: Celecoxib plus placebo
Number of subjects: 55
Study: 24495461

Group type: EXPERIMENTAL
Intervention: MDMA
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 22865728

Group type: EXPERIMENTAL
Intervention: Hadad‐Bassagasteguy (HB) flap reconstruction
Number of subjects: 20

Group type: COMPARATOR
Intervention: Synthetic or nonautologous materials for reconstruction
Number of subjects: 20
Study: 21625426

Group type: EXPERIMENTAL
Intervention: G-CSF (10 µg/kg body weight/day for 10 days)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 18346960

Group type: EXPERIMENTAL
Intervention: Clopidogrel therapy
Number of subjects: 2865
Study: 16413442

Group type: EXPERIMENTAL
Intervention: Autologous Growth Factors (AGF) combined with allograft
Number of subjects: 37

Group type: COMPARATOR
Intervention: Iliac crest bone graft (autograft)
Number of subjects: 37
Study: 12789899

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10846898

Group type: EXPERIMENTAL
Intervention: Strict control of food and fluid intake
Number of subjects: 0
Study: 9487771

Group type: EXPERIMENTAL
Intervention: Nasal plaster (NP, Breathe‐Right)
Number of subjects: 50
Study: 7933440

Group type: EXPERIMENTAL
Intervention: Continuous enteral feeding
Number of subjects: 12

Group type: COMPARATOR
Intervention: Discontinuous enteral feeding
Number of subjects: 12
Study: 3064972

Group type: EXPERIMENTAL
Intervention: Controlled-release diazepam (10 mg once daily)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Conventional diazepam (5 mg 3-times daily)
Number of subjects: 114
Study: 29891606

Group type: EXPERIMENTAL
Intervention: 3 g every day (QD) for 7 doses
Number of subjects: 18

Group type: COMPARATOR
Intervention: 3 g every other day (QOD) for 3 doses
Number of subjects: 18
Study: 26936043

Group type: EXPERIMENTAL
Intervention: New drug trials
Number of subjects: 0
Study: 25913417

Group type: EXPERIMENTAL
Intervention: Normoxia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypoxia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 23733372

Group type: EXPERIMENTAL
Intervention: Pasireotide 600 μg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Pasireotide 900 μg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Pasireotide 1200 μg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 45
Study: 20647285

Group type: EXPERIMENTAL
Intervention: Intensive individualised dietary advice for six months
Number of subjects: 93
Study: 18753810

Group type: EXPERIMENTAL
Intervention: Eye protective device
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ear protective device
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Eye protective device and ear protective device
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 16603776

Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel
Number of subjects: 338

Group type: COMPARATOR
Intervention: plain lubricant gel
Number of subjects: 338
Study: 11861728

Group type: EXPERIMENTAL
Intervention: Open carpal tunnel release with flexor tenosynovectomy
Number of subjects: 87

Group type: COMPARATOR
Intervention: Open carpal tunnel release without flexor tenosynovectomy (control)
Number of subjects: 87
Study: 9702620

Group type: EXPERIMENTAL
Intervention: Nicardipine 5 mg i.v. rapid infusion
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nicardipine 10 to 15 mg i.v. rapid infusion
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nicardipine 1.25 to 5 mg i.v. bolus
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nicardipine 5 mg i.v. bolus
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nicardipine 2.5 to 5 mg i.v. bolus with labetalol 10 mg i.v.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nicardipine as part of anesthetic regimen for ECT
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nicardipine 2.5 mg i.v. bolus with labetalol 10 mg i.v.
Number of subjects: 36
Study: 7891260

Group type: EXPERIMENTAL
Intervention: Nonnutritive sucking (NNS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 20
Study: 2239218

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate for 4 weeks
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study: 344110

Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 7045314

Group type: EXPERIMENTAL
Intervention: Oral high-dose prednisone therapy (2 mg/kg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Pulse methylprednisolone therapy (30 mg/kg/day, not to exceed 1 gm/day) followed by prednisone (2 mg/kg/day)
Number of subjects: 22
Study: 30418101

Group type: EXPERIMENTAL
Intervention: Telehealth self-monitoring (TSM)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Comprehensive outpatient management (COM)
Number of subjects: 104
Study: 29573355

Group type: EXPERIMENTAL
Intervention: Higher plasma levels of neopterin
Number of subjects: 8913

Group type: EXPERIMENTAL
Intervention: Neopterin and CRP levels above the median
Number of subjects: 8913
Study: 26615503

Group type: EXPERIMENTAL
Intervention: Monocryl® Plus suture
Number of subjects: 20

Group type: COMPARATOR
Intervention: Silk suture
Number of subjects: 20
Study: 24890542

Group type: COMPARATOR
Intervention: Prasugrel 60-mg loading dose (n = 25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ticagrelor 360-mg loading dose (n = 25)
Number of subjects: 50
Study: 22865589

Group type: EXPERIMENTAL
Intervention: Preoperative topical antimicrobial decolonization with a 5-day regimen of chlorhexidine skin rinses and intranasal mupirocin coupled with standard perioperative systemic antimicrobial prophylaxis
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard prophylaxis alone
Number of subjects: 84
Study: 18952203

Group type: COMPARATOR
Intervention: Stilt height of 0'' (no stilts)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Stilt height of 24''
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Stilt height of 40''
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foot placement with one foot forward
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Feet parallel and directly beneath the body
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foot placement with feet positioned a half shoulder width apart
Number of subjects: 20
Study: 17486917

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 40
Study: 15531906

Group type: EXPERIMENTAL
Intervention: Pegfilgrastim (12 mg single dose)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Unconjugated G-CSF (8.5 mug/kg/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both interventions post high-dose melphalan (200 mg/m2) and autografting
Number of subjects: 24
Study: 11983189

Group type: EXPERIMENTAL
Intervention: bupropion SR 300 mg/day
Number of subjects: 423

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 423
Study: 10990148

Group type: EXPERIMENTAL
Intervention: Growth hormone therapy (6.7 microg/kg/day for 12 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7608429

Group type: COMPARATOR
Intervention: Aspirin (200 mg/day)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Aspirin plus regular heparin (400 IU/kg body weight per day intravenously)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Aspirin plus low molecular weight heparin (214 UIC/kg anti‐Xa twice daily subcutaneously)
Number of subjects: 219
Study: 2109613

Group type: EXPERIMENTAL
Intervention: Disease-modifying antirheumatic drugs (DMARDs)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 606780

Group type: EXPERIMENTAL
Intervention: Whole-virus vaccines (400 CCA units/0.5 ml or 200 CCA units/0.25 ml)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Ether-extracted, subunit vaccines (with or without 1.5 mg of A1PO4/0.5 ml)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Two doses of ether-extracted, subunit virus vaccine with Hsw1N1 antigen
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Dosage regimen of two doses administered at least four weeks apart
Number of subjects: 185
Study: 30192341

Group type: EXPERIMENTAL
Intervention: Topical extra virgin olive oil for massaging
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Piroxicam gel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Paraffin oil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dry massaging
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Routine drugs alone
Number of subjects: 60
Study: 30651573

Group type: EXPERIMENTAL
Intervention: SNP rs6684439 in IL6R
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: SNP rs4845622 in IL6R
Number of subjects: 559
Study: 27531388

Group type: EXPERIMENTAL
Intervention: Anodal transcranial Direct Current Stimulation (tDCS) over the left dlPFC
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham transcranial Direct Current Stimulation (tDCS)
Number of subjects: 19
Study: 25733384

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 3982

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 3982

Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 3982

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 3982
Study: 24090427

Group type: EXPERIMENTAL
Intervention: Electromyostimulation (EMS) training (47 minutes/day, 5 days/week) for 14 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no EMS training)
Number of subjects: 8
Study: 21395680

Group type: EXPERIMENTAL
Intervention: Tropisetron (5 mg/mL)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 36
Study: 19147331

Group type: EXPERIMENTAL
Intervention: PRP group (grafted autogenous bone + PRP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: non-PRP group (grafted autogenous bone alone)
Number of subjects: 30
Study: 17457134

Group type: EXPERIMENTAL
Intervention: Sodium parecoxib (1 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15764246

Group type: EXPERIMENTAL
Intervention: TURBT+5'-DFUR (n = 47; initial 23 months)
Number of subjects: 112

Group type: COMPARATOR
Intervention: TURBT alone (n = 65, final 23 months)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 5'-DFUR administration
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 5'-DFUR
Number of subjects: 112
Study: 12391352

Group type: EXPERIMENTAL
Intervention: Thalamotomy
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Thalamic stimulation
Number of subjects: 62
Study: 10535230

Group type: EXPERIMENTAL
Intervention: Fast Track intervention (multisite, multicomponent preventive intervention including classroom program, social skills training, academic tutoring, parent training, and home visiting)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 0
Study: 7751425

Group type: EXPERIMENTAL
Intervention: IMDUR 60-mg tablets
Number of subjects: 18

Group type: COMPARATOR
Intervention: 5-ISMN 60-mg solution
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: IMDUR 60-mg tablets with food
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: IMDUR 60-mg tablets under fasted conditions
Number of subjects: 18
Study: 2215592

Group type: EXPERIMENTAL
Intervention: Fresh embryos transferred to recipients
Number of subjects: 40

Group type: COMPARATOR
Intervention: Frozen and thawed embryos transferred to recipients
Number of subjects: 40
Study: 342850

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31174889

Group type: EXPERIMENTAL
Intervention: ipafricept (IPA) in combination with carboplatin (C) and paclitaxel (P)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: ipafricept (IPA)
Number of subjects: 37